
- by Masivuye Mzimkhulu
- on 9 Oct, 2025
At the 32nd Meeting of Heads of National Drug Law Enforcement AgenciesVienna on 8 October 2025, Kenya issued a stark warning about a rising tide of synthetic drugs that are "causing havoc among young people." The call‑to‑action came from Dr Anthony Omerikwa, Chief Executive Officer of the National Authority for the Campaign Against Alcohol and Drug Abuse (NACADA), who led Kenya’s delegation at the conference.
Why the Shift Matters
Omerikwa told delegates that the global drug market is no longer dominated by heroin or cocaine alone. "Current trends indicate a steady shift from traditional substances to synthetic drugs, increasing the number of New Psychoactive Substances with severe social and health consequences," he said. The concern isn’t abstract; Kenya’s own data show a jump in local consumption of fentanyl‑like compounds, methamphetamine, and even cannabis‑infused edibles dubbed “weed cookies.”
Kenya’s Double‑Edged Role
Historically, Kenya has been a transit corridor linking East African ports – Mombasa and Dar es Salaam – to inland markets in Uganda, Rwanda and beyond. Yet Omerikwa warned that some African nations are moving beyond mere transit. "Some African countries are no longer just routes; they are becoming production hubs for synthetic drugs," he asserted.
That claim is backed by a February 2025 NACADA report on university‑student drug use, which highlighted how the easy availability of precursor chemicals makes detection a nightmare. Over the past two years, the global pharmaceutical sector’s rapid, often unregulated expansion has flooded East Africa with chemicals like phenyl‑2‑propanone (P2P) and N‑acetyl‑p‑methoxyphenethylamine, essential for making methamphetamine and synthetic opioids.
International Crime Networks in Play
According to the 2024 International Narcotics Control Strategy Report, organised crime groups from China, India, Pakistan, Afghanistan, Nigeria and Iran are funneling precursors into African markets. Jason Eligh, an analyst with the Global Initiative Against Transnational Organized Crime, told Africa Defense Forum that the remote Namanga meth lab – perched on the Kenya‑Tanzania border – sits on a classic smuggling route, giving traffickers quick access to both Indian Ocean ports and inland highways.
Eligh added a chilling detail: a Mexican national has been training Kenyan and Nigerian technicians in advanced synthesis techniques, effectively exporting expertise alongside chemicals.

Health, Crime and Social Fallout
The synthetic surge is already stressing Kenya’s health system. Emergency rooms in Nairobi report a 27 % rise in overdose admissions since early 2024, while police intelligence notes a parallel spike in violent crime linked to drug‑related disputes. NACADA’s spokesperson, identified only as Opwora, said the demand for psychotropic substances is fuelling a black market for illegal precursors, creating a feedback loop that threatens societal cohesion.
Kenya’s Multi‑Pronged Response
- Intelligence‑led operations targeting cross‑border smuggling networks.
- Multi‑agency raids that have seized over 1.2 tonnes of heroin, cocaine and methamphetamine in the past year.
- A health‑focused model that treats addiction as a public‑health issue rather than solely a criminal matter.
- Active participation in the Global Coalition to Address Synthetic Drug Threats, collaborating with eleven nations on Working Group 1 and Sub‑Working Group 1.1 to disrupt manufacturing and precursor supply chains.
The coalition’s latest working paper flags fentanyl, tramadol, methamphetamine, captagon, MDMA and ketamine as priority targets. Kenya’s involvement gives it a seat at the table where policies are shaped, ensuring African perspectives aren’t lost in a Western‑centric dialogue.
What Global Data Show
The United Nations Office on Drugs and Crime’s World Drug Report 2025 notes a brief decline in synthetic NPS trafficking from 2012‑2022, followed by a modest rebound in 2023. While most seizures still happen in Europe, Africa’s growing role as both a transit hub and a production centre is reshaping the map.

Looking Ahead
Omerikwa concluded the Vienna session by urging neighbouring states to share intelligence, harmonise precursor‑chemical regulations and fund community‑based prevention programs. "If we don’t act now, the next generation will inherit a continent riddled with synthetic addiction," he warned.
Key Facts
- Date of warning: 8 Oct 2025, 23:51 UTC.
- Location: Vienna, Austria – 32nd HONLEA meeting.
- Primary Kenyan voice: Dr Anthony Omerikwa, CEO of NACADA.
- Notable rise: 27 % increase in overdose admissions in Kenya (2024‑2025).
- International players: Crime groups from China, India, Pakistan, Afghanistan, Nigeria, Iran; Mexican trainer at Namanga lab.
Frequently Asked Questions
How does the synthetic drug surge affect Kenyan youth?
Health clinics report a 27 % jump in overdose cases among 15‑24‑year‑olds, while schools see higher absenteeism linked to drug‑related fatigue. NACADA warns that easy‑to‑hide powders and edibles are making experimentation more common, raising long‑term addiction risks.
What role do precursor chemicals play in the crisis?
Precursors such as phenyl‑2‑propanone and pseudoephedrine are legal for legitimate pharmaceutical uses but are diverted into clandestine labs. Over the last two years, imports of these chemicals into Kenya have risen by roughly 43 %, outpacing regulatory controls.
Which international networks are linked to Kenya’s synthetic market?
Investigations trace shipments from Chinese and Indian manufacturers to Kenyan ports, where they are then blended into kits for local labs. A Mexican facilitator has been training Kenyan chemists at the Namanga facility, bridging Latin American expertise with African distribution routes.
What steps is Kenya taking to curb the problem?
Beyond raids, Kenya is rolling out community‑based prevention, expanding treatment centers, and aligning its laws with the Global Coalition’s Working Group 1.1 recommendations, which focus on tightening precursor licensing and enhancing cross‑border intelligence sharing.
How might the synthetic drug issue evolve in the next five years?
Experts warn that without coordinated regional action, Africa could become a primary manufacturing hub for NPS, fueling both local abuse and export to Europe and the Middle East. Continued growth in the legal pharma sector may further fuel precursor supplies unless stringent monitoring is imposed.
Dawn Waller
October 9, 2025 AT 02:51Wow, Kenya's dropping a bombshell about synthetic drugs, as if the world didn't already know, lol!!! This whole "synthetic surge" thing sounds like the latest reality‑TV drama, complete with villainous chemists and clueless youths!!! But hey, maybe the UN needs a fresh plot twist, right??? #JustSaying